Clinical trial
Acute Neurophysiological and Autonomic Responses to a Respiratory-Coupled Sound-Based Digital Therapeutic (BELL-001) Versus Sham, Followed by 7 Days of Home Use, in Adults With Insomnia Symptoms: A Randomized, Sham-Controlled Study
NCT07872007 is registered in ClinicalTrials.gov with BELL Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Acute Neurophysiological and Autonomic Responses to a Respiratory-Coupled Sound-Based Digital Therapeutic (BELL-001) Versus Sham, Followed by 7 Days of Home Use, in Adults With Insomnia Symptoms: A Randomized, Sham-Controlled Study
- Lead sponsor
- BELL Therapeutics Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 18, 2025
- Completion date
- February 18, 2026
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
insomnia